Publikasjoner 2023

Estimated Lifetime Gained With Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials

Bretthauer M, Wieszczy P, Løberg M, Kaminski MF, Werner TF, Helsingen LM, Mori Y, Holme Ø, Adami HO, Kalager. JAMA Intern Med. 2023 Nov 1;183(11):1196-1203. doi: 10.1001/jamainternmed.2023.3798.PMID: 37639247
Level 2 Journal Impact Factor of 39

The Future of Cancer Screening-Guided Without Conflicts of Interest

Adami HO, Kalager M, Bretthauer M. JAMA Intern Med. 2023 Oct 1;183(10):1047-1048. doi: 10.1001/jamainternmed.2023.4064.PMID: 37639267
Level 2 Journal Impact Factor of 39

The New European Medical Device Regulation: Balancing Innovation and Patient Safety

Bretthauer M, Gerke S, Hassan C, Ahmad OF, Mori Y. Ann Intern Med. 2023 Jun;176(6):844-848. doi: 10.7326/M23-0454. Epub 2023 Apr 18.PMID: 37068279 Review.
Level 2 Impact Factor 39.2

A Comparison of Risk Classification Systems of Colorectal Adenomas: A Case-Cohort Study

Jodal HC, Wieszczy-Szczepanik P, Klotz D, Herfindal M, Barua I, Tag P, Helsingen LM, Refsum E, Holme Ø, Adami HO, Bretthauer M, Kalager M, Løberg M. Gastroenterology. 2023 Aug; 165(2):483-491.e7. doi: 10.1053/j.gastro.2023.04.028. Epub 2023 May 3.PMID: 37146913 Free article.
Level 2 Impact factor 29.4

Combination of Mucosa-Exposure Device and Computer-Aided Detection for Adenoma Detection During Colonoscopy: A Randomized Trial

Spadaccini M, Hassan C, Rondonotti E, Antonelli G, Andrisani G, Lollo G, Auriemma F, Iacopini F, Facciorusso A, Maselli R, Fugazza A, Bambina Bergna IM, Cereatti F, Mangiavillano B, Radaelli F, Di Matteo F, Gross SA, Sharma P, Mori Y, Bretthauer M, Rex DK, Repici A; CERTAIN Study Group. Gastroenterology. 2023 Jul;165(1):244-251.e3. doi: 10.1053/j.gastro.2023.03.237. Epub 2023 Apr 14.PMID: 37061169 Clinical Trial.
Level 2 Impact factor 29.4

Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study

Yu J, Refsum E, Wieszczy P, Helsingen LM, Perrin V, Högdén A, Løberg M, Blom J, Bretthauer M, Adami HO, Ye W, Kalager M. BMJ Open Gastroenterol. 2023 May;10(1):e001037. doi: 10.1136/bmjgast-2022-001037.PMID: 37142293 Free PMC article.
Level 1 Impact factor 3.1

Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply

Bretthauer M, Løberg M, Kaminski MF. N Engl J Med. 2023 Jan 26;388(4):378-379. doi: 10.1056/NEJMc2215192.PMID: 36720146 No abstract available.
Level 2 Journal Impact factor of 158.5

What is my risk, doctor? How to convey disease risk and treatment effects

Bretthauer M, Kalager M. BMJ. 2023 Jun 16;381:e075289. doi: 10.1136/bmj-2022-075289.PMID: 37328165 No abstract available.
Level 2 Impact factor 107.7

Authors' Reply: Interpreting epidemiologic studies of colorectal cancer prevention

Song M, Bretthauer M. Eur J Epidemiol. 2024 Jan;39(1):99. doi: 10.1007/s10654-023-01070-9. Epub 2023 Nov 10.PMID: 37950085 No abstract available.
Level 2 Impact factor 13.6

New American College of Physicians Guidance on Colorectal Cancer Screening: Less Is More
 

Bretthauer M, Yang YX. Ann Intern Med. 2023 Aug;176(8):1127-1128. doi: 10.7326/M23-1695. Epub 2023 Aug 1.PMID: 37523706 No abstract available.
Level 2 Impact Factor 39.2

A novel framework for incorporating patient values and preferences in making guideline recommendations: guideline panel surveys

Zeng L, Helsingen LM, Bretthauer M, Agoritsas T, Vandvik PO, Mustafa RA, Busse J, Siemieniuk RAC, Lytvyn L, Li SA, Yang M, Yan L, Zhang L, Brignardello-Petersen R, Guyatt GH. J Clin Epidemiol. 2023 Sep;161:164-172. doi: 10.1016/j.jclinepi.2023.07.003. Epub 2023 Jul 13.PMID: 37453455 Free article.
Level 2 Impact factor 7.2

Qualitative study of guideline panelists: innovative surveys provided valuable insights regarding patient values and preferences

Zeng L, Li SA, Yang M, Yan L, Helsingen LM, Bretthauer M, Agoritsas T, Vandvik PO, Mustafa RA, Busse J, Siemieniuk RAC, Lytvyn L, Zhang L, Brignardello-Petersen R, Guyatt GH. J Clin Epidemiol. 2023 Sep;161:173-180. doi: 10.1016/j.jclinepi.2023.07.014. Epub 2023 Jul 29.PMID: 37517505 Free article.
Level 2 Impact factor 7.2

A pilot study of implementation of endoscopic sleeve gastroplasty (ESG) in Norway

Tønnesen CJ, Hjelmesæth J, Aabakken L, Lund RS, Johnson LK, Hertel JK, Kalager M, Løberg M, Bretthauer M. Scand J Gastroenterol. 2023 Jul-Dec;58(10):1180-1184. doi: 10.1080/00365521.2023.2204389. Epub 2023 Apr 26.PMID: 37128713
Level 1 Impact factor 1.8

Interpreting epidemiologic studies of colonoscopy screening for colorectal cancer prevention: understanding the mechanisms of action is key

Song M, Bretthauer M. Eur J Epidemiol. 2023 Sep;38(9):929-931. doi: 10.1007/s10654-023-01043-y. Epub 2023 Sep 4.PMID: 37667139 No abstract available.
Level 2 Impact factor 13.6

Gastrointestinal endoscopy devices and the European Union Medical Device Regulation: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

Bretthauer M, Mori Y, Zessner-Spitzenberg J, Kaminski MF, Siersema PD, Ponchon T, Messmann H, Gralnek IM, Bisschops R, Hassan C. Endoscopy. 2023 Jun;55(6):578-581. doi: 10.1055/a-2052-2540. Epub 2023 Apr 20.PMID: 37080238 Free article.
Level 2 Impact factor 9.3

Informed consent for endoscopic procedures: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

Everett SM, Triantafyllou K, Hassan C, Mergener K, Tham TC, Almeida N, Antonelli G, Axon A, Bisschops R, Bretthauer M, Costil V, Foroutan F, Gauci J, Hritz I, Messmann H, Pellisé M, Roelandt P, Seicean A, Tziatzios G, Voiosu A, Gralnek IM. Endoscopy. 2023 Oct;55(10):952-966. doi: 10.1055/a-2133-3365. Epub 2023 Aug 9.PMID: 37557899 Free article.
Level 2 Impact factor 9.3

Performance and safety of diagnostic EUS FNA/FNB and therapeutic ERCP in patients with borderline resectable and locally advanced pancreatic cancer - results from a population-based, prospective cohort study

Farnes I, Paulsen V, Verbeke CS, Tønnesen CJ, Aabakken L, Labori KJ. Scand J Gastroenterol. 2023 Dec 21:1-7. doi: 10.1080/00365521.2023.2290456. Online ahead of print. PMID: 38126766
Level 1 Impact factor 1.8

Colonic distribution of FMT by different enema procedures compared to colonoscopy - proof of concept study using contrast fluid

Skjevling LK, Hanssen HM, Valle PC, Goll R, Juul FE, Arlov Ø, Johnsen PH. BMC Gastroenterol. 2023 Oct 23;23(1):363. doi: 10.1186/s12876-023-02979-x.PMID: 37872499 Free PMC article. Clinical Trial.
Level 1 Impact factor 2.4

High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinoma

Wang TM, Xiao RW, He YQ, Zhang WL, Diao H, Tang M, Mai ZM, Xue WQ, Yang DW, Deng CM, Liao Y, Zhou T, Li DH, Wu YX, Chen XY, Zhang J, Li XZ, Zhang PF, Zheng XH, Zhang SD, Hu YZ, Cai Y, Zheng Y, Zhang Z, Zhou Y, Jin G, Bei J, Mai HQ, Sun Y, Ma J, Hu Z, Liu J, Lung ML, Adami HO, Ye W, Lam TH, Shen H, Jia WH. Am J Hum Genet. 2023 Jul 6;110(7):1162-1176. doi: 10.1016/j.ajhg.2023.06.003. Epub 2023 Jun 22.PMID: 37352861 Free PMC article.
Level 2 Impact factor 9.8

Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, Smedby KE, Kleinstern G, Hjalgrim H, Besson C, Skibola CF, Morton LM, Brooks-Wilson AR, Teras LR, Breeze C, Arias J, Adami HO, Albanes D, Anderson KC, Ansell SM, Bassig B, Becker N, Bhatti P, Birmann BM, Boffetta P, Bracci PM, Brennan P, Brown EE, Burdett L, Cannon-Albright LA, Chang ET, Chiu BCH, Chung CC, Clavel J, Cocco P, Colditz G, Conde L, Conti DV, Cox DG, Curtin K, Casabonne D, De Vivo I, Diepstra A, Diver WR, Dogan A, Edlund CK, Foretova L, Fraumeni JF Jr, Gabbas A, Ghesquières H, Giles GG, Glaser S, Glenn M, Glimelius B, Gu J, Habermann TM, Haiman CA, Haioun C, Hofmann JN, Holford TR, Holly EA, Hutchinson A, Izhar A, Jackson RD, Jarrett RF, Kaaks R, Kane E, Kolonel LN, Kong Y, Kraft P, Kricker A, Lake A, Lan Q, Lawrence C, Li D, Liebow M, Link BK, Magnani C, Maynadie M, McKay J, Melbye M, Miligi L, Milne RL, Molina TJ, Monnereau A, Montalvan R, North KE, Novak AJ, Onel K, Purdue MP, Rand KA, Riboli E, Riby J, Roman E, Salles G, Sborov DW, Severson RK, Shanafelt TD, Smith MT, Smith A, Song KW, Song L, Southey MC, Spinelli JJ, Staines A, Stephens D, Sutherland HJ, Tkachuk K, Thompson CA, Tilly H, Tinker LF…See abstract for full author list ➔Leukemia. 2023 Oct;37(10):2142. doi: 10.1038/s41375-023-01978-x.PMID: 37666943 No abstract available.
Level 2 Impact factor 11.4

Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population-based patient cohort study in southern China

Du Y, Feng R, Chang ET, Yin L, Huang T, Li Y, Zhou X, Huang Y, Zhou F, Su C, Xiao X, Jia W, Zheng Y, Adami HO, Zeng Y, Cai Y, Zhang Z, Xu M, Ye W. Int J Cancer. 2023 Jul 15;153(2):290-301. doi: 10.1002/ijc.34524. Epub 2023 Apr 7.PMID: 36965052
Level 2 Impact factor 6.4

Oral fungal profiling and risk of nasopharyngeal carcinoma: a population-based case-control study

Chen Y, Li W, Chang ET, Debelius JW, Manoharan L, Zheng Y, Li Y, Huang G, Adami HO, Knight R, Cai Y, Zhang Z, Ye W. EBioMedicine. 2023 Oct;96:104813. doi: 10.1016/j.ebiom.2023.104813. Epub 2023 Sep 28.PMID: 37776725 Free PMC article.
Level 1 Impact factor 11.1

Overall and Cervical Cancer Survival in Patients With and Without Mental Disorders

Herweijer E, Wang J, Hu K, Valdimarsdóttir UA, Adami HO, Sparén P, Sundström K, Fang F. JAMA Netw Open. 2023 Sep 5;6(9):e2336213. doi: 10.1001/jamanetworkopen.2023.36213.PMID: 37773493 Free PMC article.
Level 1 Impact factor 13.8

Cancer risk following surgical removal of tonsils and adenoids - a population-based, sibling-controlled cohort study in Sweden

Liang J, Huang Y, Yin L, Sadeghi F, Yang Y, Xiao X, Adami HO, Ye W, Zhang Z, Fang F. BMC Med. 2023 May 24;21(1):194. doi: 10.1186/s12916-023-02902-x.PMID: 37226237 Free PMC article
Level 2 Impact factor 9.3

International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts

Timmins IR, Jones ME, O'Brien KM, Adami HO, Aune D, Baglietto L, Bertrand KA, Brantley KD, Chen Y, Clague DeHart J, Clendenen TV, Dossus L, Eliassen AH, Fletcher O, Fournier A, Håkansson N, Hankinson SE, Houlston RS, Joshu CE, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Lynch BM, May AM, Mellemkjær L, Milne RL, Palmer JR, Ricceri F, Rohan TE, Ruddy KJ, Sánchez MJ, Shu XO, Smith-Byrne K, Steindorf K, Sund M, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zheng W, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ. J Clin Oncol. 2023 Dec 11:JCO2301101. doi: 10.1200/JCO.23.01101. Online ahead of print. PMID: 38079601
Level 2 Impact factor 45.4

Interactive association between insomnia symptoms and sleep duration for the risk of dementia-a prospective study in the Swedish National March Cohort

Tan X, Åkerstedt T, Lagerros YT, Åkerstedt AM, Bellocco R, Adami HO, Ye W, Pei JJ, Wang HX. Age Ageing. 2023 Sep 1;52(9):afad163. doi:10.1093/ageing/afad163.PMID: 37676841 Free PMC article.
Level 2 Impact factor 6.7

Invasive cervical cancer, precancerous lesions, and cervical screening participation among women with mental illness in Sweden: a population-based observational study

Hu K, Wang J, Sparén P, Herweijer E, Sjölander A, Adami HO, Valdimarsdóttir U, Sundström K, Fang F. Lancet Public Health. 2023 Apr;8(4):e266-e275. doi: 10.1016/S2468-2667(23)00026-9.PMID: 36965981 Free article.
Level 2 Impact factor 50

Prospective study of weight loss and all-cause-, cardiovascular-, and cancer mortality

Tolvanen L, Ghilotti F, Adami HO, Ye W, Bonn SE, Bellocco R, Lagerros YT. Sci Rep. 2023 Apr 6;13(1):5669. doi: 10.1038/s41598-023-32977-8.PMID: 37024633 Free PMC article.
Level 1 Impact factor 4.6

Risk of Psychiatric Disorders Among Spouses of Patients With Cancer in Denmark and Sweden

Hu K, Liu Q, László KD, Wei D, Yang F, Fall K, Adami HO, Ye W, Valdimarsdóttir UA, Li J, Fang F. JAMA Netw Open. 2023 Jan 3;6(1):e2249560. doi: 10.1001/jamanetworkopen.2022.49560.PMID: 36602801 Free PMC article.
Level 1 Impact factor 13.8

The association of short and long sleep with mortality in men and women

Åkerstedt T, Bellocco R, Widman L, Eriksson J, Ye W, Adami HO, Trolle Lagerros Y. J Sleep Res. 2023 May 16:e13931. doi: 10.1111/jsr.13931. Online ahead of print. PMID: 37192602
Level 1 Impact factor 4.4

Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis

O'Grady TJ, Rinaldi S, Michels KA, Adami HO, Buring JE, Chen Y, Clendenen TV, D'Aloisio A, DeHart JC, Franceschi S, Freedman ND, Gierach GL, Giles GG, Lacey JV, Lee IM, Liao LM, Linet MS, McCullough ML, Patel AV, Prizment A, Robien K, Sandler DP, Stolzenberg-Solomon R, Weiderpass E, White E, Wolk A, Zheng W, Berrington de Gonzalez A, Kitahara CM. Int J Epidemiol. 2023 Dec 18:dyad172. doi: 10.1093/ije/dyad172. Online ahead of print.PMID: 38110618
Level 2 Impact factor 7.7

Reply

Jodal HC, Wieszczy-Szczepanik P, Løberg M. Gastroenterology. 2023 Dec;165(6):1583-1584. doi: 10.1053/j.gastro.2023.09.022. Epub 2023 Sep 20.PMID: 37739088  No abstract available.
Level 2 Impact factor 29.4

Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study

Jodal HC, Akwiwu EU, Lemmens M, Delis-van Diemen PM, Klotz D, Leon LG, Lakbir S, de Wit M, Fijneman RJA, van Leerdam ME, Dekker E, Spaander MCW, Meijer GA, Løberg M, Coupé VMH, Kalager M, Carvalho B. Cancer Res Commun. 2023 Nov 13;3(11):2292-2301. doi: 10.1158/2767-9764.CRC-23-0186.PMID: 37921412  Free PMC article.
Level 1

Colonoscopy quality improvement after initial training: A cross-sectional study of intensive short-term training

Schult AL, Hoff G, Holme Ø, Botteri E, Seip B, Ranheim Randel K, Darre-Næss O, Owen T, Nilsen JA, Nguyen DH, Johansen K, de Lange T. Endosc Int Open. 2023 Jan 26;11(1):E117-E127. doi: 10.1055/a-1994-6084. eCollection 2023 Jan.PMID: 36712907 Free PMC article.
Level 1 Impact factor 2.6

In response: 15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality

Juul FE, Cross AJ, Pinsky P, Senore C, Løberg M. Ann Intern Med. 2023 Jun;176(6):eL230025. doi: 10.7326/L23-0025. PMID: 37335997  No abstract available.
Level 2 Impact Factor 39.2

Commentary

Kaminski MF, Pilonis N. Endoscopy. 2023 Dec;55(12):1150. doi: 10.1055/a-2178-9552. Epub 2023 Nov 28.PMID: 38016459  No abstract available.
Level 2 Impact factor 9.3

Positive fecal immunochemical test but negative colonoscopy: what's next?

Pilonis N. Endoscopy. 2023 Dec;55(12):1070-1071. doi: 10.1055/a-2182-6316. Epub 2023 Nov 3.PMID: 37922956  No abstract available.
Level 2 Impact factor 9.3

Benefits and challenges in implementation of artificial intelligence in colonoscopy: World Endoscopy Organization position statement

Mori Y, East JE, Hassan C, Halvorsen N, Berzin TM, Byrne M, von Renteln D, Hewett DG, Repici A, Ramchandani M, Al Khatry M, Kudo SE, Wang P, Yu H, Saito Y, Misawa M, Parasa S, Matsubayashi CO, Ogata H, Tajiri H, Pausawasdi N, Dekker E, Ahmad OF, Sharma P, Rex DK. Dig Endosc. 2023 May;35(4):422-429. doi: 10.1111/den.14531. Epub 2023 Mar 13.PMID: 36749036 Review.
Level 1 Impact factor 5.5

Artificial intelligence and upper gastrointestinal endoscopy: what is the optimal study design?

Halvorsen N, Mori Y. Minerva Surg. 2023 Feb;78(1):81-85. doi: 10.23736/S2724-5691.22.09810-0.PMID: 36843555 Review.
Level 1 Impact factor 1.4

Real-Time Computer-Aided Detection of Colorectal Neoplasia During Colonoscopy : A Systematic Review and Meta-analysis

Hassan C, Spadaccini M, Mori Y, Foroutan F, Facciorusso A, Gkolfakis P, Tziatzios G, Triantafyllou K, Antonelli G, Khalaf K, Rizkala T, Vandvik PO, Fugazza A, Rondonotti E, Glissen-Brown JR, Kamba S, Maida M, Correale L, Bhandari P, Jover R, Sharma P, Rex DK, Repici A. Ann Intern Med. 2023 Sep;176(9):1209-1220. doi: 10.7326/M22-3678. Epub 2023 Aug 29.PMID: 37639719 Review.
Level 2 Impact Factor 39.2

Artificial Intelligence-Aided Endoscopy and Colorectal Cancer Screening

Spadaccini M, Massimi D, Mori Y, Alfarone L, Fugazza A, Maselli R, Sharma P, Facciorusso A, Hassan C, Repici A. Diagnostics (Basel). 2023 Mar 14;13(6):1102. doi: 10.3390/diagnostics13061102.PMID: 36980409 Free PMC article. Review.
Level 1 Impact factor 3.6

Cost of artificial intelligence: Elephant in the room and its cage

Hassan C, Repici A, Mori Y. Dig Endosc. 2023 Nov;35(7):900-901. doi: 10.1111/den.14567. Epub 2023 May 9.PMID: 37160614 No abstract available.
Level 1 Impact factor 5.5

Whole slide image-based prediction of lymph node metastasis in T1 colorectal cancer using unsupervised artificial intelligence

Takashina Y, Kudo SE, Kouyama Y, Ichimasa K, Miyachi H, Mori Y, Kudo T, Maeda Y, Ogawa Y, Hayashi T, Wakamura K, Enami Y, Sawada N, Baba T, Nemoto T, Ishida F, Misawa M. Dig Endosc. 2023 Nov;35(7):902-908. doi: 10.1111/den.14547. Epub 2023 Apr 10.PMID: 36905308
Level 1 Impact factor 5.5

The Pros and Cons of Artificial Intelligence in Endoscopy

Hassan C, Mori Y, Sharma P. Am J Gastroenterol. 2023 Oct 1;118(10):1720-1722. doi: 10.14309/ajg.0000000000002287. Epub 2023 Apr 12.PMID: 37052360 No abstract available.
Level 2 Impact factor 10.2

Diagnostic performance of endocytoscopy with normal pit-like structure sign for colorectal low-grade adenoma compared with conventional modalities

Suzuki K, Kudo SE, Kudo T, Misawa M, Mori Y, Ichimasa K, Maeda Y, Hayashi T, Wakamura K, Baba T, Ishda F, Hamatani S, Inoue H, Yokoyama K, Miyachi H. DEN Open. 2023 May 8;4(1):e238. doi: 10.1002/deo2.238. eCollection 2024 Apr.PMID: 37168271 Free PMC article.
Level 1

Colonoscopy setting and impact on statistical significance in Artificial Intelligence trials

Spadaccini M, Rondonotti E, Radaelli F, Mori Y, Hassan C, Repici A. Endoscopy. 2023 Dec;55(12):1151. doi: 10.1055/a-2131-3315. Epub 2023 Nov 28.PMID: 38016460 No abstract available.
Level 2 Impact factor 9.3

Computer-aided detection in real-world colonoscopy: enhancing detection or offering false hope?

Misawa M, Kudo SE, Mori Y. Lancet Gastroenterol Hepatol. 2023 Aug;8(8):687-688. doi: 10.1016/S2468-1253(23)00166-8. Epub 2023 Jun 1.PMID: 37269873 No abstract available.
Level 2 Impact factor 35.7

Enhancing artificial intelligence-doctor collaboration for computer-aided diagnosis in colonoscopy through improved digital literacy

Mori Y, Jin EH, Lee D. Dig Liver Dis. 2023 Dec 16:S1590-8658(23)01072-1. doi: 10.1016/j.dld.2023.11.033. Online ahead of print.PMID: 38105144 Free article.
Level 1 Impact factor 4.5

Correction to: Gaussian affinity and GIoU-based loss for perforation detection and localization from colonoscopy videos

Jiang K, Itoh H, Oda M, Okumura T, Mori Y, Misawa M, Hayashi T, Kudo SE, Mori K. Int J Comput Assist Radiol Surg. 2023 May;18(5):807. doi: 10.1007/s11548-023-02899-x.PMID: 37052792  No abstract available.
Level 1 Impact level 3.0

Gaussian affinity and GIoU-based loss for perforation detection and localization from colonoscopy videos

Jiang K, Itoh H, Oda M, Okumura T, Mori Y, Misawa M, Hayashi T, Kudo SE, Mori K. Int J Comput Assist Radiol Surg. 2023 May;18(5):795-805. doi: 10.1007/s11548-022-02821-x. Epub 2023 Mar 13.PMID: 36913126
Level 1 Impact level 3.0

Lack of Effectiveness of Computer Aided Detection for Colorectal Neoplasia: A Systematic Review and Meta-Analysis of Nonrandomized Studies

Patel HK, Mori Y, Hassan C, Rizkala T, Radadiya DK, Nathani P, Srinivasan S, Misawa M, Maselli R, Antonelli G, Spadaccini M, Facciorusso A, Khalaf K, Lanza D, Bonanno G, Rex DK, Repici A, Sharma P. Clin Gastroenterol Hepatol. 2023 Dec 4:S1542-3565(23)00968-0. doi: 10.1016/j.cgh.2023.11.029. Online ahead of print. PMID: 38056803
Level 1 Impact factor 12.6

Reply

Randel KR, Botteri E, Holme Ø. Gastroenterology. 2023 Jun;164(7):1351. doi: 10.1053/j.gastro.2019.08.035. Epub 2019 Aug 31.PMID: 31479657  No abstract available.
Level 2 Impact factor 29.4

Are we ready for the cold snare revolution?

Holme Ø. Endoscopy. 2023 Oct;55(10):938-939. doi: 10.1055/a-2025-0997. Epub 2023 Feb 24.PMID: 36827990 No abstract available.
Level 2 Impact factor 9.3

Association between use of low-dose aspirin and detection of colorectal polyps and cancer in a screening setting

Nafisi S, Randel KR, Støer NC, Veierød MB, Hoff G, Holme Ø, Schult AL, Botteri E. Dig Liver Dis. 2023 Aug;55(8):1126-1132. doi: 10.1016/j.dld.2023.01.156. Epub 2023 Feb 6.PMID: 36754644  Free article.
Level 1 Impact level 4.5

Lower participation among immigrants in colorectal cancer screening in Norway

Bhargava S, Botteri E, Berthelsen M, Iqbal N, Randel KR, Holme Ø, Berstad P. Front Public Health. 2023 Sep 26;11:1254905. doi: 10.3389/fpubh.2023.1254905. eCollection 2023.PMID: 37822535  Free PMC article.
Level 1 Impact factor 5.2

Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial

Chaber-Ciopinska A, Kiprian D, Wieszczy P, Bielasik A, Bugajski M, Januszewicz W, Jarzabski A, Niemiec M, Mroz A, Kawecki A, Regula J, Kaminski MF. Pol Arch Intern Med. 2023 Oct 26;133(10):16462. doi: 10.20452/pamw.16462. Epub 2023 Mar 14.PMID: 36916462 Free article. Clinical Trial.
Level 1 Impact Factor 4.8

HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial

Glinska P, Komerska K, Janik B, Olkowicz J, Jedrzejewska I, Macios A, Wieszczy P, Kaminski MF, Arbyn M, Nowakowski A. BMC Cancer. 2023 Nov 17;23(1):1118. doi: 10.1186/s12885-023-11597-5.PMID: 37978452 Free PMC article.
Level 1 Impact Factor 3.8

Tarmkreftscreening også for yngre?

Jodal HC, Bretthauer M, Løberg M. Tidsskr Nor Laegeforen. 2023 Dec 6;143(18). doi: 10.4045/tidsskr.23.0553. Print 2023 Dec 12.PMID: 38088289 Free article. Norwegian. No abstract available.
Level 1

Følger Helsedirektoratets retningslinjer internasjonale standarder for troverdighet?

Langeland EA, Pisani SER, Kalager M, Bretthauer M, Helsingen LM. Tidsskr Nor Laegeforen. 2023 Oct 9;143(14). doi: 10.4045/tidsskr.23.0110. Print 2023 Oct 10.PMID: 37830968 Free article. Norwegian.
Level 1

Tarmflora og tarmsykdom – en edruelig formaning

Juul FE, Hov JER, Trøseid M, Johnsen PH, Valeur J. Tidsskr Nor Laegeforen. 2023 Jun 26;143(10). doi: 10.4045/tidsskr.23.0121. Print 2023 Jun 27.PMID: 37376933 Free article. Norwegian. No abstract available.
Level 1

Measuring broad-spectrum antibiotic use in hospitals with established versus new indicators

Skaare D, Hannisdal A, Kalager M, Berild D.Tidsskr Nor Laegeforen. 2023 Apr 24;143(6). doi: 10.4045/tidsskr.22.0427. Print 2023 Apr 25.PMID: 37097231 Free article. English, Norwegian.
Level 1

[Correction: Measuring broad-spectrum antibiotic use in hospitals with established versus new indicators]

Skaare D, Hannisdal A, Kalager M, Berild D. Tidsskr Nor Laegeforen. 2023 May 4;143(7). doi: 10.4045/tidsskr.23.0301. Print 2023 May 9.PMID: 37158510 Free article. Norwegian. No abstract available.
Level 1

Kjønn og helse, utdanning og forskning

Feiring E, Løberg M, Bjaalie JG, Dyb GA, Harbo HF. Tidsskr Nor Laegeforen. 2023 Jul 7;143(11). doi: 10.4045/tidsskr.23.0408. Print 2023 Aug 15.PMID: 37589360  Free article. Norwegian. No abstract available.
Level 1

Forebygger probiotika nekrotiserende enterokolitt hos ekstremt premature? (Do probiotics prevent necrotising enterocolitis in extremely preterm neonates?)

[Article in Norwegian] Tidsskr Nor Laegeforen. 2023 Mar 13;143(4). doi: 10.4045/tidsskr.22.0544. Print 2023 Mar 14. Helene Gråbø, Kjetil Kjeldstad Garborg, Hallvard Reigstad PMID: 36919293 DOI: 10.4045/tidsskr.22.0544 Free article. No abstract available
Level 1

Cancerscreening förlänger inte livet

Adami HO, Bretthauer M. Kalager M. Debattartikel. Svenska Dagbladet August 28, 2023.